Vaxxinity Correlations
| VAXXDelisted Stock | USD 2.72 0.19 6.53% |
The current 90-days correlation between Vaxxinity and Lyra Therapeutics is -0.1 (i.e., Good diversification). The correlation of Vaxxinity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Vaxxinity Correlation With Market
Good diversification
The correlation between Vaxxinity and DJI is -0.19 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Vaxxinity and DJI in the same portfolio, assuming nothing else is changed.
Vaxxinity |
The ability to find closely correlated positions to Vaxxinity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vaxxinity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vaxxinity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vaxxinity to buy it.
Moving together with Vaxxinity Pink Sheet
Moving against Vaxxinity Pink Sheet
| 0.69 | DOMH | Dominari Holdings | PairCorr |
| 0.63 | VCNX | Vaccinex | PairCorr |
| 0.58 | VERU | Veru Inc Fiscal Year End 13th of December 2024 | PairCorr |
| 0.34 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.33 | DRMA | Dermata Therapeutics | PairCorr |
| 0.33 | DTIL | Precision BioSciences | PairCorr |
| 0.32 | SABSW | SAB Biotherapeutics | PairCorr |
| 0.8 | VRCA | Verrica Pharmaceuticals | PairCorr |
| 0.76 | EDIT | Editas Medicine | PairCorr |
| 0.7 | VIRI | Virios Therapeutics Llc | PairCorr |
| 0.65 | VIRX | Viracta Therapeutics | PairCorr |
| 0.65 | VTVT | vTv Therapeutics | PairCorr |
| 0.63 | VSTM | Verastem | PairCorr |
| 0.51 | SRZNW | Surrozen Warrant | PairCorr |
| 0.45 | CDTTW | Conduit Pharmaceuticals Symbol Change | PairCorr |
| 0.44 | VTYX | Ventyx Biosciences | PairCorr |
| 0.41 | VIGL | Vigil Neuroscience | PairCorr |
| 0.4 | VTGN | VistaGen Therapeutics | PairCorr |
| 0.34 | VNDA | Vanda Pharmaceuticals | PairCorr |
| 0.31 | DYAI | Dyadic International | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Vaxxinity Pink Sheet performing well and Vaxxinity Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Vaxxinity's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TARS | 2.81 | (0.34) | 0.00 | (1.08) | 0.00 | 7.43 | 19.42 | |||
| LIAN | 2.99 | 0.08 | 0.01 | 0.24 | 3.34 | 6.76 | 20.98 | |||
| ALDX | 4.10 | 0.37 | 0.19 | 0.20 | 3.28 | 8.59 | 35.39 | |||
| TVTX | 2.54 | 0.37 | 0.13 | 0.36 | 2.68 | 5.70 | 17.29 | |||
| ETON | 1.63 | 0.35 | 0.13 | 1.13 | 1.65 | 3.72 | 12.22 | |||
| GPCR | 3.68 | 0.25 | 0.04 | 0.62 | 4.32 | 5.86 | 68.36 | |||
| IOBT | 4.18 | 0.42 | 0.07 | 2.55 | 4.30 | 9.09 | 26.19 | |||
| ERAS | 3.43 | 0.17 | 0.06 | 0.21 | 4.05 | 6.44 | 26.07 | |||
| ASLN | 5.79 | (2.32) | 0.00 | (34.82) | 0.00 | 8.75 | 58.28 | |||
| LYRA | 2.91 | (0.13) | (0.02) | 0.02 | 3.20 | 7.14 | 19.85 |
View Vaxxinity Related Equities
| Risk & Return | Correlation |
Vaxxinity Corporate Management
| Peter MD | Global VP | Profile | |
| Louis IV | CoFounder Chairman | Profile | |
| Jon Harrison | Chief Officer | Profile | |
| Mei JD | CEO Director | Profile | |
| Ulo MD | Chief Officer | Profile | |
| Benjamin Matone | VP Relations | Profile | |
| Mark Joinnides | Chief Staff | Profile |
Still Interested in Vaxxinity?
Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.